Provided by Tiger Fintech (Singapore) Pte. Ltd.

InspireMD

2.46
+0.04001.65%
Post-market: 2.460.00000.00%16:04 EDT
Volume:43.01K
Turnover:106.43K
Market Cap:75.36M
PE:-3.12
High:2.50
Open:2.48
Low:2.43
Close:2.42
Loading ...

InspireMD Secures CE Mark Approval for CGuard® Prime EPS, Paving Way for European Launch

Reuters
·
13 Jun

InspireMD Holds Annual Stockholders Meeting and Elections

TIPRANKS
·
04 Jun

InspireMD Inc. Appoints Michael Lawless as New Chief Financial Officer Amidst Strategic Growth Phase

Reuters
·
04 Jun

InspireMD Inc. Conducted Annual Stockholders Meeting

Reuters
·
04 Jun

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

THOMSON REUTERS
·
04 Jun

InspireMD Is Maintained at Overweight by Piper Sandler

Dow Jones
·
13 May

InspireMD (NSPR) Gets a Buy from Lake Street

TIPRANKS
·
12 May

InspireMD Inc. Reports Q1 2025 Financial Results

TIPRANKS
·
10 May

InspireMD Inc’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
10 May

InspireMD Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

InspireMD Q1 EPS $(0.22) Misses $(0.20) Estimate, Sales $1.53M Beat $1.45M Estimate

Benzinga
·
09 May

InspireMD Reports First Quarter 2025 Financial Results

THOMSON REUTERS
·
09 May

InspireMD Q1 Basic EPS USD -0.22

THOMSON REUTERS
·
09 May

InspireMD Q1 Operating Expenses USD 11.752 Million

THOMSON REUTERS
·
09 May

InspireMD Q1 Gross Profit USD 292 Thousand

THOMSON REUTERS
·
09 May

InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
07 May

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

GlobeNewswire
·
30 Apr

BRIEF-Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Apr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Apr

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
08 Apr